Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer Patients



Status:Archived
Conditions:Alzheimer Disease
Therapuetic Areas:Neurology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:March 2010

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A 90-week, Multi-center, Randomized, Double-blind, Placebo-controlled Study in Patients With Mild Alzheimer's Disease (AD) to Investigate the Safety, Tolerability and Abeta-specific Antibody Response Following Repeated i.m. Injections of Adjuvanted CAD106


This study will assess the safety, tolerability and Abeta-specific antibody response of
repeated intra-muscular injections of adjuvanted CAD106 in patients with mild Alzheimer's
Disease.



We found this trial at
6
sites
Indiana Univeristy School of Medicine
Indianapolis, Indiana 46202
?
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Alpine Clinical Research
Boulder, Colorado 80304
?
mi
from
Boulder, CO
Click here to add this to my saved trials
ATP Clinical Research, Inc.
Costa Mesa, California 92626
?
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Memory Enhancement Center of America
Eatontown, New Jersey 01772
?
mi
from
Eatontown, NJ
Click here to add this to my saved trials
Sunrise Clinical Research, Inc.
Hollywood, Florida 33021
?
mi
from
Hollywood, FL
Click here to add this to my saved trials
Premiere Research Institute
West Palm Beach, Florida 33407
?
mi
from
West Palm Beach, FL
Click here to add this to my saved trials